In this Sunday edition of Business Insider Today, we're talking about the highs and lows of AI in the workforce so far.
Completed enrollment in Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa; topline data expected mid-2026Appointed Kevin Lind to Board of DirectorsExpanded leadership team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results